| HOME >> BIOLOGY >> TECHNOLOGY |
In addition to the documents referenced above, Renovis files or
furnishes annual, quarterly and current reports, proxy statements and other
information with the Securities and Exchange Commission. You may read and
copy any reports, statements or other information filed or furnished by
Renovis at the SEC's Public Reference Room at Station Place, 100 F Street,
N.E., Washington, D.C. 20549. You can request copies of these documents by
writing to the SEC and paying a fee for the copying cost. Please call the
SEC at 1-800-SEC-0330 for more information about the operation of the
Public Reference Room. Renovis's SEC filings are also available to the
public at the SEC's web site at http://www.sec.gov, or at
http://www.renovis.com.
RENOVIS, INC.
Condensed Statements of Operations
(All amounts in thousands, except share and per share amounts)
Three Months Twelve Months
Ended December 31, Ended December 31,
2007 2006 2007 2006
(unaudited)
Contract revenue $1,317 $2,150 $9,767 $10,428
Operating expenses:
Research and
development 6,207 7,400 26,266 28,112
General and
administrative 2,859 3,946 20,531 15,595
Total operating
expenses 9,066 11,346 46,797 43,707
Loss from operations (7,749) (9,196) (37,030) (33,279)
Other income 981 1,220 4,215 4,903
Net loss (6,768) (7,976) (32,815) (28,376)
Basic and diluted net
loss per share
'/>"/>
| SOURCE Renovis, Inc. Copyright©2008 PR Newswire. All rights reserved |